The NHS is changing how it buys medical technology, placing patient benefit, value for money and waiting list impact beside the price tag. The cheapest stapler in the cupboard has responded by insisting that nobody has ever asked it to do anything beyond being cheap.
The new value based procurement guidance moves away from a system where cost could dominate the conversation. Medical devices are now expected to work properly, protect patients and avoid creating a larger bill further along the corridor. The stapler has called this an attack on its entire professional identity.
The NHS spends around £10 billion a year on medical technology. That is a sizeable cupboard, and officials now want to know whether its contents are useful rather than merely available at a suspicious discount. This has left the stapler facing the first performance review in its long career.
At the Directorate of Things That Work, procurement lead Nora Invoice said the new approach would consider how equipment performs for patients and staff over time. “We are asking whether a device improves care and survives contact with reality,” she said. “The stapler has submitted a twelve page statement explaining that paper jams build character.”
The guidance follows trials involving devices that reduced infections, hospital admissions or clinical follow up time. Thirteen NHS trusts are due to pilot the approach, with wider rollout expected in early 2026. Objects that survived for years by being inexpensive and familiar are now discovering that familiarity is not the same as a defence.
Chief Value For Money Poet Basil Receipt said the old system had encouraged a dangerous misunderstanding. “Some people thought value meant finding the smallest number on a spreadsheet,” he said. “We now understand that a larger number can be cheaper if it prevents everyone from buying the same thing again while looking disappointed.”
The stapler has requested a formal assessment of its wider contribution. It has pointed to its low purchase price, modest footprint and ability to remain in a drawer for several financial years without demanding training. It has supplied no evidence that it can close a wound, shorten a waiting list or stop a patient returning to hospital, but believes these requirements are becoming unnecessarily specific.
The procurement change is not an instruction to buy the fanciest gadget. It is a request to consider the whole patient journey, including the expensive part where the bargain becomes somebody else’s problem. The stapler lost the tender, but was retained as a warning to future spreadsheets that a low price is not a personality. It is merely the opening bid from an object hoping nobody asks what happens next.
Real story: Department of Health and Social Care and NHS England.
